KRAS and neoplasm: They orchestrate LD formation within tumor tissues via intricate pathways linked to inflammation, hypoxia, and acidosis, intersecting with key oncogenic pathways like PTEN, KRAS, and FOXO3/Sirtuin6 [5, 43].